Pathophysiology and Risk Factors of Non-alcoholic Fatty Liver Disease: Review Article

Effects of vitamin d3 on ppar-α and its target gene nfkbia on a rat model of high carbohydrate high fat diet induced non alcoholic steatohepatitis

Role of Some Adipokines in Nonalcoholic Fatty Liver Diseases

Targeting Asprosin/ Nrf2 Pathway in the Potential Protective Effect of Co-enzyme Q10 and/or Exercise on High-Fat Diet Induced Non-alcoholic Fatty Liver Disease in Rats

Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy

Non alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment

Transforming Growth Factor Beta One and Non Alcoholic Fatty Liver Disease

Role of Fatty Acid Binding Protein 1 in Non- Alcoholic Fatty Pancreatic Disease with and without Diabetes Mellitus

Does Farnesoid X receptor (FXR) Have a Role in NAFLD Progression ?

The Role of Microbiota In The Occurrence of Non-Alcoholic Fatty Liver Disease